is lantus a glp-1 (insulin glargine): Uses, Side Effects, Alternatives & More is lantus a glp-1 Tresiba

Those with kidney disease, previous kidney stones, or eye conditions face heightened risk and require baseline kidney and ophthalmology evaluation before attempting combination therapy

The incidence of NAION was 17 events in the semaglutide group compared to 6 in the non-GLP-1 RA group

Always talk to your doctor about the risks and benefits of any treatment

The FDA prescribing information includes a boxed warning regarding the potential risk of thyroid C-cell tumors (observed in rodent studies, though human relevance remains uncertain) and a contraindication for patients with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2

Lancet Diab

These medications can help qualified patients, but results depend on nutrition, activity, dose tolerance, side effects, refill access, and realistic long-term planning